Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Q4 and Year End

<< Previous

Bullboard Posts

Next >>

Comment by Starkickeron Mar 31, 2023 12:31pm

83 Views

Post# 35372057

RE:RE:Q4 and Year End

I'll give you a few reasons. Outright ownership of assets, debt free, $24M in cash, reduced cash burn, increasing revenue, and expectations of positive EBITDA and cash flow first half of 2024. The Arrangement with VIVO will be a one step back two steps forward situation, and the transition from B2B sales is done, the anchor chain is broken. Cleared for takeoff.

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide